Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1997 Jan 23;120(3):439–446. doi: 10.1038/sj.bjp.0700932

Evidence against a role of cytochrome P450-derived arachidonic acid metabolites in endothelium-dependent hyperpolarization by acetylcholine in rat isolated mesenteric artery

Mitsuhiro Fukao *,*, Yuichi Hattori *, Morio Kanno *, Ichiro Sakuma *, Akira Kitabatake *
PMCID: PMC1564487  PMID: 9031747

Abstract

  1. In rat mesenteric artery, acetylcholine (ACh) causes endothelium-dependent hyperpolarization by releasing endothelium-derived hyerpolarizing factor (EDHF). Recent evidence suggests that EDHF may be a cytochrome P450-derived arachidonic acid metabolite. The aim of the present study was to investigate whether such a metabolite is indeed contributing to ACh-induced hyperpolarization observed in rat mesenteric artery.

  2. The phospholipase A2 inhibitor quinacrine (30 μM) nearly completely eliminated ACh-induced hyperpolarization. However, the hyperpolarizing effect of pinacidil was also abolished in the presence of quinacrine.

  3. The imidazole antimycotic agents ketoconazole (50 μM), clotrimazole (30 μM) and miconazole (10 μM), which bind to the heme moiety of cytochrome P450, eliminated not only ACh-induced hyperpolarizations but also those induced by pinacidil. SKF525A (30 μM), a prototype inhibitor of the enzyme, also abolished the hyperpolarizing responses to both agents. In contrast, neither 17-octadecynoic acid (10 μM), a mechanism-based inhibitor of cytochrome P450 metabolism of fatty acids, nor eicosatetraynoic acid (20 μM), an inhibitor of all arachidonic acid metabolic pathways, altered ACh-induced hyperpolarization. Furthermore, the hyperpolarization was unaffected by the preferential inhibitors of specific cytochrome P450 isozymes, α-naphtoflavone (1 μM), diedthyldithiocarbamate (50 μM), metyrapone (20 μM) and troleandomycin (10 μM).

  4. Pretreatment of rats with lipopolysaccharide (2 mg kg−1) and exposure to nitroprusside (10 μM), both of which are expected to inhibit cytochrome P450 activity due to nitric oxide overproduction, were without effect on ACh-induced hyperpolarization. Pretreatment of rats for 3 days with pentobarbitone (80 mg kg−1 day−1), a cytochrome P450 inducer, also did not affect the hyperpolarizing response to ACh.

  5. Arachidonic acid in concentrations up to 100 μM had no detectable effect on smooth muscle membrane potential. 11,12-Epoxyeicosatrienoic acid (EET, 10 μM), one of cytochrome P450-derived epoxygenase metabolites of arachidonic acid, elicited a small endothelium-independent membrane hyperpolarization. The hyperpolarizing response to EET was blocked by glibenclamide (30 μM), in contrast to the response to ACh.

  6. These results suggest that the contribution of a cytochrome P450-derived metabolite of arachidonic acid to ACh-induced hyperpolarization via EDHF release is minimal or absent in rat mesenteric artery.

Keywords: Endothelium-derived hyperpolarizing factor, acetylcholine, hyperpolarization, arachidonic acid, cytochrome P450, epoxyeicosatrienoic acid, rat mesenteric artery

Full Text

The Full Text of this article is available as a PDF (454.1 KB).


Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES